Article
Evaluation of atazanavir Ctrough, atazanavir genotypic inhibitory quotient, and baseline HIV genotype as predictors of a 24-week virological response in highly drug-experienced, HIV-infected patients treated with unboosted atazanavir.
The new microbiologica - 1 Apr 2005
Gianotti Nicola, Seminari Elena, Guffanti Monica, Boeri Enzo, Villani Paola, Regazzi Mario, Bigoloni Alba, Schira Giulia, Tiberi Simon, Fusetti Giuliana, Lazzarin Adriano, Castagna Antonella
Abstract excerpt
The objective of this study was to evaluate virological and pharmacological determinants of a 24-week virological response to unboosted atazanavir (ATV) in highly drug-experienced HIV-infected patients. Among patients enrolled in the ATV Expanded Access Program, those with HIV-RNA >1000 copies/mL...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.